Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-02-13 5:00 pm Sale | 13G | BRISTOL MYERS SQUIBB COMPANY BMY | VANGUARD GROUP INC | 198,155,594 9.74% | -4,772,026 (-2.35%) | View |
| 2024-01-25 4:59 pm Sale | 13G | BRISTOL MYERS SQUIBB COMPANY BMY | BlackRock Inc. BLK | 168,098,227 8.3% | -4,622,150 (-2.68%) | View |
| 2023-12-04 4:13 pm Purchase | 13G | AVIDITY BIOSCIENCES INC RNA | BRISTOL MYERS SQUIBB CO BMY | 5,075,304 6.4% | 5,075,304 (New Position) | View |
| 2023-02-09 11:12 am Purchase | 13G | BRISTOL MYERS SQUIBB COMPANY BMY | VANGUARD GROUP INC | 202,927,620 9.54% | 3,093,137 (+1.55%) | View |
| 2023-02-07 2:10 pm Purchase | 13G | BRISTOL MYERS SQUIBB COMPANY BMY | BlackRock Inc. BLK | 172,720,377 8.1% | 3,493,671 (+2.06%) | View |
| 2022-02-09 3:33 pm Purchase | 13G | BRISTOL MYERS SQUIBB COMPANY BMY | VANGUARD GROUP INC | 199,834,483 9% | 494,025 (+0.25%) | View |
| 2022-01-31 5:59 pm Sale | 13G | BRISTOL MYERS SQUIBB COMPANY BMY | BlackRock Inc. BLK | 169,226,706 7.6% | -3,238,098 (-1.88%) | View |
| 2021-11-19 4:15 pm Purchase | 13G | COMPUGEN LTD CGEN | BRISTOL MYERS SQUIBB CO BMY | 4,757,058 5.5% | 4,757,058 (New Position) | View |
| 2021-07-26 5:10 pm Purchase | 13G | CELULARITY INC CELU | BRISTOL MYERS SQUIBB CO BMY | 11,953,274 9.9% | 11,953,274 (New Position) | View |
| 2021-04-05 5:28 pm Purchase | 13G | SUTRO BIOPHARMA INC STRO | BRISTOL MYERS SQUIBB CO BMY | 1,726,197 3.8% | 1,726,197 (New Position) | View |
| 2021-04-05 5:27 pm Purchase | 13G | IDEAYA BIOSCIENCES INC IDYA | BRISTOL MYERS SQUIBB CO BMY | 1,633,254 5.1% | 1,633,254 (New Position) | View |
| 2021-04-05 5:26 pm Unchanged | 13D | AGIOS PHARMACEUTICALS INC AGIO | BRISTOL MYERS SQUIBB CO BMY | 0 0% | 0 (Unchanged) | View |
| 2021-04-05 5:26 pm Purchase | 13G | JOUNCE THERAPEUTICS INC. JNCE | BRISTOL MYERS SQUIBB CO BMY | 3,456,463 7.6% | 3,456,463 (New Position) | View |
| 2021-04-05 5:25 pm Purchase | 13G | IKENA ONCOLOGY INC IKNA | BRISTOL MYERS SQUIBB CO BMY | 2,133,142 5.9% | 2,133,142 (New Position) | View |
| 2021-02-10 10:39 am Purchase | 13G | BRISTOL MYERS SQUIBB COMPANY BMY | VANGUARD GROUP INC | 199,340,458 8.82% | 4,480,304 (+2.30%) | View |
| 2021-01-28 5:56 pm Purchase | 13G | BRISTOL MYERS SQUIBB COMPANY BMY | BlackRock Inc. BLK | 172,464,804 7.6% | 1,121,358 (+0.65%) | View |
| 2020-07-16 5:01 pm Purchase | 13D | ACCELERON PHARMA INC XLRN | BRISTOL MYERS SQUIBB CO BMY | 7,008,510 12% | 7,008,510 (New Position) | View |
| 2020-02-12 09:24 am Purchase | 13G | BRISTOL MYERS SQUIBB COMPANY BMY | VANGUARD GROUP INC | 194,860,154 8.32% | 63,160,559 (+47.96%) | View |
| 2020-02-05 11:26 am Purchase | 13G | BRISTOL MYERS SQUIBB COMPANY BMY | BlackRock Inc. BLK | 171,343,446 7.3% | 55,770,368 (+48.26%) | View |
| 2020-01-28 11:34 am Sale | 13G | BRISTOL MYERS SQUIBB COMPANY BMY | WELLINGTON MANAGEMENT GROUP LLP | 83,470,877 3.57% | -37,676,158 (-31.10%) | View |